Yelin Jeong
Incheon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Multifaceted roles of KCTD17 in cellular homeostasis and disease.
Journal: BMB reports
Published: September 01, 2026
E3 Ubiquitin Ligases in MASH-Associated Liver Fibrosis: Mechanisms and Therapeutic Opportunities.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: June 26, 2026
Hepatocyte KCTD17-mediated SERPINA3 inhibition determines liver fibrosis in metabolic dysfunction-associated steatohepatitis.
Journal: Experimental & molecular medicine
Published: February 12, 2025
KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression.
Journal: Clinical and molecular hepatology
Published: May 17, 2024
Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases.
Journal: Experimental & molecular medicine
Published: May 01, 2023
Kctd17-mediated Chop degradation promotes adipogenic differentiation.
Journal: Biochemical and biophysical research communications
Published: February 06, 2023
Hepatocyte Kctd17 Inhibition Ameliorates Glucose Intolerance and Hepatic Steatosis Caused by Obesity-induced Chrebp Stabilization.
Journal: Gastroenterology
Published: March 24, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026